药师帮 预期股息率 % : 0.00% (今日)
药师帮预期股息率 %(Forward Dividend Yield %)的相关内容及计算方法如下:
预期股息率 %是预期未来12个月的股息与当前股价之间的比率。 截至今日, 药师帮 的 预期股息率 % 为 0.00%。
药师帮预期股息率 %或其相关指标的历史排名和行业排名结果如下所示:
★ ★ ★ ★ ★
药师帮的预期股息率 %没有参与排名。
截至2023年12月, 药师帮 过去半年 的 股息支付率 为 0.00。
药师帮 预期股息率 % (HK:09885 预期股息率 %) 行业比较
在医药零售(三级行业)中,药师帮 预期股息率 %与其他类似公司的比较如下:
药师帮 预期股息率 % (HK:09885 预期股息率 %) 分布区间
在医疗机构和服务(二级行业)和医疗保健(一级行业)中,药师帮 预期股息率 %的分布区间如下:
药师帮 预期股息率 % (HK:09885 预期股息率 %) 计算方法
预期股息率 %是预期未来12个月的股息与当前股票价格之间的比率。在投资实践中,股息率是衡量企业是否具有投资价值的重要标尺之一。价值大师(GuruFocus)的预期股息率 %由数据供应商直接提供。
药师帮 预期股息率 % (HK:09885 预期股息率 %) 解释说明
从长远来看,股息收益是股票投资总收益的重要贡献之一。普林斯顿大学的Elroy Dimson,Paul Marsh和Mike Staunton(2002年)的研究发现,以市场为导向的投资组合在包括股利再投资的情况下,所产生的财富几乎是同一个投资组合仅依靠资本收益获得的财富的85倍。
股息也可能使投资者享有较低的税率。
药师帮 预期股息率 % (HK:09885 预期股息率 %) 相关词条
感谢查看价值大师中文站为您提供的药师帮预期股息率 %的详细介绍,请点击以下链接查看与药师帮预期股息率 %相关的其他词条:
药师帮 (HK:09885) 公司简介
一级行业:医疗保健
二级行业:医疗机构和服务
公司网站:https://www.ysbang.cn
公司地址:No. 8 Brand Street, No. 397 Xingang Middle Road, Yaoshibang Building, TIT Creative Industry Zone, Guangzhou, CHN
公司简介:YSB Inc is a digital pharmaceutical platform serving businesses outside of hospitals in China. The Company is committed to using digitalization to empower participants in the out-of-hospital pharmaceutical market, including pharmaceutical companies, distributors, vendors, pharmacies and primary healthcare institutions, and strives to bring pharmaceutical health products and services to the downstream safely and efficiently, so that users can easily obtain a large number of comprehensive and high-quality drugs at a fair and transparent price. It has turned the process of pharmaceutical transaction and service into a digitalized, standardized and scalable one.
二级行业:医疗机构和服务
公司网站:https://www.ysbang.cn
公司地址:No. 8 Brand Street, No. 397 Xingang Middle Road, Yaoshibang Building, TIT Creative Industry Zone, Guangzhou, CHN
公司简介:YSB Inc is a digital pharmaceutical platform serving businesses outside of hospitals in China. The Company is committed to using digitalization to empower participants in the out-of-hospital pharmaceutical market, including pharmaceutical companies, distributors, vendors, pharmacies and primary healthcare institutions, and strives to bring pharmaceutical health products and services to the downstream safely and efficiently, so that users can easily obtain a large number of comprehensive and high-quality drugs at a fair and transparent price. It has turned the process of pharmaceutical transaction and service into a digitalized, standardized and scalable one.